Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis

Clinical trial NCT03231033 · COMPLETED

Trial details

NCT number: NCT03231033
Sponsor: Children's Hospital Medical Center, Cincinnati
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Pulmonary Alveolar Proteinosis

Start date: 2017-08-17
Primary completion: 2019-04-02
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.